Research location
Giengen an der Brenz
Germany
Advertisement
Research activity in Giengen an der Brenz
GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 9 trials and 9 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Giengen an der Brenz
9 linked trials · page 1 of 1Characterizing Guideline Adoption and Treatment Quality in Clinical Routine of German HFrEF CareNCT06004453 · 2023-04-03 · 1 site observation
COMPLETED
A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 DiabetesNCT02681094 · 2016-02-26 · 1 site observation
COMPLETED
Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With SulphonylureaNCT02471404 · 2015-09-21 · 1 site observation
COMPLETED
A Study in Adults With Type 2 DiabetesNCT01421459 · 2011-09-01 · 1 site observation
COMPLETED
A Study in Patients With Type 2 DiabetesNCT01408095 · 2011-09-01 · 1 site observation
WITHDRAWN
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 1 site observation
TERMINATED
Efficacy and Safety of LCZ696A in Patients With Essential HypertensionNCT00549770 · 2007-09-01 · 1 site observation
COMPLETED
12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With MetforminNCT00473525 · 2007-07-01 · 1 site observation
COMPLETED
Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential HypertensionNCT00441350 · 2007-07-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.